Ompoy, Clarence Jade F.

HRN: 22-56-08  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/07/2024
MUPIROCIN 2%, 15G (TUBE)
10/07/2024
10/14/2024
TOPICAL
As Needed
BID
Phlebitis
Waiting Final Action 

Indication:  Empiric Then Culture-directed    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: